Pharmaceutical manufacturers of Toltrazuril

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Axyntis Group, established in 2007, is the foremost independent multi-location entity in the field of fine chemicals in France, generating an annual revenue of €90 million. Axyntis has evolved into a significant manufacturer of APIs in France through acquisitions and collaborations. It encompasses two sectors (colorants and fine chemicals) and emphasizes diversification and pioneering initiatives. The company operates three cGMP facilities in France, two of which are approved by the FDA. It offers CDMO services to partners for their API or advanced intermediate projects, from the initial development phase to the commercial stage, inclusive of preparative chromatography (Kyrapharm subsidiary). Additionally, it markets exclusive APIs.

Over the last few years, we have emerged as India’s largest animal health company with presence in 100+ countries. Our logotype is inspired by nature and its different forms and shapes -from a microscopic view of the skin texture to footprint of a chosen animal. The circular shape evokes the idea of protection and control. It’s a closed and perfect shape that is naturally balanced, reminiscing the brand idea “Animals’ Source of Health”. Pronounced A-lee-vee-rah, the name is a variant of two Latin words Elvira, word for ‘white, pure, clean’ and Alleviare, word for ‘relief’. It speaks about our commitment to improving animals’ life and well-being at every stage. We are Alivira! Our focus on R&D is taking us even further, and we are committed to applying cutting-edge resources to improve health and well-being at every stage of animals’ lives. All along our processes, we are committed to quality, but moreover, we are committed to safety. That is our guarantee for effective medicines.

Jiangsu Lingyun Pharmaceutical Co., Ltd. was founded in 2000, is a professional engaged in the international new raw materials (chemical synthetic drugs and biological fermentation semi-synthetic drugs) research and development, manufacturing, sales, service and other integration of national high-tech enterprises. Company registered capital of 36.94 million yuan, 200 million yuan of fixed assets. The headquarters and R & D base are located in the center of the Yangtze River Delta - Jincheng Town, Jintan District, Changzhou City, Jiangsu Province. In addition to the production base located in the headquarters of Jintan District, Changzhou, Jiangsu, the company also has a production base in Huai'an Industrial Park, Jiangsu (a wholly-owned subsidiary ), covers an area of 200,000 square meters, more than 400 employees.